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This report is an overview of poliomyelitis surveillance in Tunisia from 1991 to 1996. In 
all, 2088 stool specimens, collected from 152 acute flaccid paralysis (AFP) cases and 
from 1747 of their healthy contacts were investigated. Virus isolation was done 
systematically in RD and HEp-2C cell lines and isolated viruses were typed by sero- 
neutralisation as polioviruses or non-polio enteroviruses. Poliovirus isolates were 
analysed systematically for their wild or vaccine-related origin by two methods - one 
based on antigenic differences and one on genetic differences between strains. All type 2 
polioviruses were vaccine-related and most wild viruses belonged to polio serotype 3. 
Wild polio type 3 viruses were detected in 1991 and 1992 in six cases of paralytic polio. 
A silent circulation of wild polio 1 and wild polio 3 was detected in 1994. No wild virus 
was detected in Tunisia from 1995 onwards. Wild polioviruses were sequenced and 
compared with Tunisian wild strains isolated during the 1980s, as well as other 
genotypes from the international database. These investigations revealed a single 
Tunisian polio 3 genotype that has been circulating from 1985 to 1994 and two different 
polio 1 genotypes. These results reflect effective control strategies within the country and 
contribute to the improvement of the polio eradication programme effectiveness at  
national and global levels. 
Introduction 
Paralytic poliomyelitis is the second viral disease after 
smallpox which has been proposed as the target for 
worldwide eradication [ 11. An eradication programme 
was started in 1988 and today, poliomyelitis is very 
rare in all developed and many developing countries 
[2]. The key operational components of this pro- 
gramme are mass vaccination of the population and 
effective virological surveillance of wild virus circula- 
tion. This surveillance is based on a complete 
virological investigation of all acute flaccid paralysis 
(AFP) cases, including virus isolation from stool 
specimens collected fiom patients and from their 
contacts and serotyping of isolated viruses, followed 
by intratypic differentiation of all polioviruses as wild 
or vaccine-derived. The certification of poliomyelitis 
eradication in a region requires that no wild poliovirus 
is isolated despite an effective AFP surveillance 
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system. Because of the extensive use of attenuated 
oral polio vaccine (OPV) which results in frequent 
isolation of vaccine viruses from children, intratypic 
differentiation of isolated polioviruses constitutes an 
essential step in the diagnostic process. Various meth- 
ods have been developed; some are based on the 
antigenic phenotype with a panel of monoclonal 
antibodies or intratype-specific cross-absorbed antisera 
[3-71. Others are genomic methods based on probe 
hybridisation or PCR amplification [8- 181. Molecular 
characterisation of isolated strains by sequencing of 
highly variable genomic regions gives more detailed 
information about the geographic origin and the 
relationship between strains [ 19-25]. 
In Tunisia, triple dose OPV coverage in infants 
< 12months of age has been >90% since 1988. 
Paralytic poliomyelitis has become rare, with an 
average of only one case per year since 1988 (two 
cases in 1988, no cases in 1989 and 1990, three cases 
in 1991, four cases in 1992 and no cases from 1993 to 
1996). Virological surveillance of AFP cases was 
started in 199 1. Subsequently, six paralytic polio cases 
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due to wild poliovirus type 3 occurred within a period 
of 5 months from December 1991 to April 1992 [26]. 
It was suggested that this higher incidence of the 
disease was the result of an improved surveillance 
system [27]. These were the last wild polio paralytic 
cases notified in the country. More detailed informa- 
tion about the epidemiological situation of poliomye- 
litis and the national programme for AFP surveillance 
in Tunisia has been published [28]. 
In this report, an overview of the virological 
surveillance of poliomyelitis in Tunisia from 1991 to 
1996 is given. The results of the molecular analysis of 
poliovirus strains isolated during this period are 
presented. 
Materials and methods 
Subjects 
A total of 2088 stool specimens was investigated, 
collected between Dec. 1991 and Dec. 1996; 341 
specimens were from 152 AFP cases (infants aged 4 
months- 16 years, average 4 years). Contacts of 137 
cases were sampled. The total number of stool samples 
collected was 1747 (average of 13 contacts per AFP 
index case; range 2-187). 
Virus isolation and identijication 
All stool specimens were processed for virus isolation 
and identification by standard protocols recommended 
by WHO [29]. Briefly, after a decontamination step 
with chloroform and antibiotics, stools were inoculated 
onto RD and HEp2-Cincinatti cell lines. Specimens 
were considered negative if no cytopathic effect (CPE) 
was detected 14 days after inoculation. For positive 
samples, isolated viruses were tested for sero-neutrali- 
sation of CPE with trivalent and bivalent pools of 
antisera against polio 1, polio 2 and polio 3 and pools 
against Coxsackie B and echoviruses (RIVM, the 
Netherlands). 
Intratypic differentiation of polioviruses 
All polioviruses were tested systematically by two 
distinct methods to establish their wild or vaccine 
origin [30]: one method was based on antigenic 
differences and the second was based on genetic 
differences between strains. The antigenic method 
was an ELISA with cross-absorbed intratype-specific 
rabbit antisera [3,5,6]. The genetic method was a 
hybridisation assay with recombinant riboprobes which 
specifically hybridise to the genome of vaccine-related 
isolates [ 13, 181. The combination of these two meth- 
ods was recently shown to be the most appropriate and 
recommended for use in the WHO polio laboratory 
network [30]. Polioviruses found to be unrelated to the 
OPV strains by one of the two methods were then 
analysed by partial genome sequencing. 
Sequence analysis 
Genetic characterisation of wild strains was performed 
by partial sequencing of a PCR product including the 
150-bp fragment used for molecular epidemiological 
analysis and located in the VP1/2A junction region 
between nucleotides 3287 and 3436 for polio 3, and 
3296 and 3445 for polio 1 [31]. 
Virus preparation. Wild viruses were re-inoculated on 
HEp2C cell cultures which were freeze-thawed when 
full cytopathic effect was obtained. The cell culture 
suspensions were subsequently clarified by centrifuga- 
tion (20 rnin at 1500 9) and used directly for cDNA 
synthesis. 
Reverse transcription and PCR. 20U of RNAasin 
(1 pl) and 50 pM (1 pl) of downstream primer UC11 
(nt 3485-3504) were added to 12 pl of virus suspen- 
sion. The mixture was heated for 5 rnin at 80°C, 5 rnin 
at 42°C and then immediately chilled on ice. Six pl  of 
a reverse transcription mixture were then added 
containing 10 r n ~  each of four deoxynucleotides, 1 U 
Avian Myeloblastosis Virus Reverse Transcriptase 
(Gibco BRL), 6 m ~  MgC12, 50mM Tris-HC1 
(PH 8.3), 10mM DTT, 40mM KC1. The mixture was 
incubated for 30 min at 42"C, heat-denatured for 5 rnin 
at 95°C and immediately stored on ice for a minimum 
of 5min. The whole volume of the cDNA was 
subsequently used for PCR: 80 pl  of a mixture were 
added, containing 50 PM of upstream primer UG1 (nt 
2402-242 l), 1.25 U Taq polymerase (Amersham), 
50 mM KCl, 1.5 mM MgC12, 10 mM Tris-HC1 (pH 
8.3). Light mineral oil (Sigma) 100 pl  was layered on 
to the samples, which were then subjected to 30 cycles 
of 10 s denaturation at 94"C, 1 min annealing at 45°C 
and 1 rnin extension at 70°C in a programmable 
thermal cycler (Perkin Elmer Cetus). A final extension 
of 10 rnin at 70°C completed the procedure. Finally, 
5 pl of the RT-PCR product were loaded on to a 
agarose 1.5% gel (Sigma) to which ethidium bromide 
was added to estimate the size and amount of amplified 
DNA. For strains which could not be amplified, RT- 
PCR was conducted again in the same conditions, but 
with different dowmstream primer, UC 13 (3629-3648) 
or another upstream primer UG19 (2870-2891), or 
both. 
Purijication of the RT-PCR products. The remaining 
PCR products were electrophoresed again in a low 
melting gel 0.8% containing ethidium bromide and the 
band of interest was cut out of the gel and purified by 
phenol extraction and ethanol precipitation. The DNA 
was resuspended in 20 pl of sterile distilled water. 
Sequencing of PCR products. Purified PCR products 
were sequenced by the dideoxy method with the 
Sequenase kit (United States Biochemical), following 
the manufacturers recommendations. Samples were 
electrophoresed through a polyacrylamide 7% gel 
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which was then fixed for 15-39 min dried and exposed 
to X-ray film for 2 days. 
Data analysis. Sequence relationship among polio- 
virus genomes (dendrograms) was analysed with the 
UPGMA program (Gene Work DNA and Protein 
Analysis Package, 2, 3; intelliGenetics). Sequences of 
Tunisian strains were compared with each other and 
with other strains isolated in the Mediterranean and 
African regions. 
Results 
AFP detection and investigation rates 
The number of AFP cases detected and those viro- 
logically investigated by year are shown in Table 1. 
The population under 15 years in Tunisia is estimated 
at c. 3 million. Accordingly, the AFP detection rate per 
100 000 children aged < 15 years increased from 0.2 in 
1991 to 1.5 and 1.3% in 1995 and 1996 respectively. 
The investigation rate (cases investigated/cases de- 
tected) was >80% after 1992. 
Virus isolation, serotyping and intratypic 
differen tiation 
Of the 2088 stool specimens tested, 1848 were 
negative; polioviruses were isolated in 10 1 specimens 
and non-polio enteroviruses (NPEV) in 139 specimens. 
The number of polio positives, by year, in paralytic 
cases and in contacts, is given in Table 1. Intratypic 
differentiation was performed by ELISA and probe 
hybridisation for all poliovirus isolates : 29 polio 1, 12 
polio 2 and 45 polio 3 (five stools contained a mixture 
of more than one polio serotype). The results were 
concordant between the two methods for all strains. 
Serotypes and intratypic differentiation, according to 
the year of isolation, in paralytic cases or in the healthy 
population, are shown in Fig. 1. All type 2 polioviruses 
were found to be vaccine-related. All type 1 polio- 
viruses were also vaccine-related, except for one strain 
isolated in 1994 from a healthy contact of an AFP case. 
No type 3 polioviruses isolated in 1991 and 1992 were 
related to OPV strains. Viruses from two contacts of an 
AFP case detected in 1994 were also not of vaccine- 
i 
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Fig. 1. Serotypes and intratypic differentiation of polio- 
viruses isolated from (a) healthy children and (b) cases 
of paralytic poliomyelitis: A, vaccine-related type 1 ; A, 
wild-type 1; 0, vaccine-related type 2; B, wild-type 2; 
0, vaccine-related type 3; 0, wild-type 3. 
type. All type 3 polioviruses isolated in 1993, 1995 and 
1996 were vaccine-related. 
Geographic distribution, clinical features and 
case classiJication 
The six paralytic cases caused by wild polio 3 in 1991 
and 1992 occurred in five distinct geographical areas. 
With the exception of the second case in 1991, which 
occurred in a contact of the first case, no epidemio- 
logical link could be found between the other cases. 
Some polio 3 wild-type strains isolated in 1993 and 
1988 were from the same district. The classification of 
AFP cases as polio or non-polio was done by a national 
committee comprising neurologists, epidemiologists, 
paediatricians, infectious disease specilaists and repre- 
sentatives from the National Poliomyelitis Reference 
Laboratory and the National Immunization Programme. 
The case classification was based on the results of 
virological investigation, the clinical features of the 
disease and electromyography, the clinical evolution of 
the symptoms and the results of a systematic follow-up 
visit 60 days afier onset of paralysis. Among the six 
AFP cases reported in 1991, three were classified as 
poliomyelitis cases, wild polio 3 was identified in two 
cases and one patient was lost to follow-up before stool 
Table 1. Studied population and poliovirus isolation 
AFP cases Stools collected from patients Stools collected from contacts 
Detected Investigated Polio positive 
Year (Detection rate*) (Investigation rate+) Total cases (stools) Total Polio positive 
1991 
1992 
1993 
1994 
1995 
1996 
Total 
~~~ ~~ 
6 (0.2) 2 (33%) 10 2 (10) 30 6 
18 (0.6) 18 (100%) 42 5 (9) 679 15 
28 (0.9) 26 (92%) 52 2 (3) 208 17 
29 (0.9) 28 (96%) 64 3 (7) 226 5 
45 (1.5) 39 (86%) 91 4 (7) 363 9 
41 (1.3) 39 (95%) 82 2 (3) 24 1 10 
167 (-) 152 (91%) 34 1 18 (39) 1747 62 
*Per 100000 children aged < 15 years. 
t Investigated/detected. 
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specimens could be obtained. In 1992, among the 18 
AFP cases reported, four were confirmed as poliomye- 
litis due to wild-type 3 poliovirus. In 1993, no wild 
virus was detected and vaccine-derived polioviruses 
were detected in three paralytic cases among which 
only one was classified as vaccine-associated paralytic 
poliomyelitis. 
In 1994, all AFP cases detected were classified as 
non-polio-related. The AFP case in which wild 
polioviruses type 1 and type 3 were identified in the 
contacts was not considered by the committee as a 
poliomyelitis case according to the following criteria. 
(i) The virological investigation of the case itself 
proved negative - two stool specimens collected 
within 14 days of onset of paralysis and received by 
the laboratory within 24 h in an adequate condition 
were found to be negative. (ii) Clinical and electro- 
myographic features were highly compatible with a 
Guillain-Barrk syndrome - symmetrical paralysis of 
the two legs, albumin-cytologic dissociation in the 
cerebro-spinal fluid, slowed conduction and decreased 
motor amplitudes by electromyography. (iii) There was 
complete clinical and electromyographical recovery 
with no persistent sequelae. The isolation of wild 
polioviruses in the contacts of this case were consid- 
ered to represent detection of silent circulation of wild 
poliovirus. All AFP cases detected in 1995 and 1996 
were classified as non-polio-related. 
Relationships among wild polioviruses 
Genomic sequencing was performed on eight selected 
wild strains: the wild polio 1 isolated in 1994 
(PVl/MEDl25/TUN94), one of the two wild polio 3 
viruses isolated in 1991 (PV3/KEBILI3/TUN91), the 
viruses isolated from four polio cases in 1992 and 
another strain isolated from a healthy child in a 
different district (PV3 /TOZEUR18/TUN92, PV3 / 
KEF54/TUN92, PV3 /GAFSAl2/TUN92, PV3/ 
NEFTA55/TUN92, PV3 /SIDIBOUZ62/TUN92) and 
one of the two wild polio 3 strains isolated in 1994 
(PV3/MED 126/TUN94). Two supplemental serotype 1 
wild strains, isolated in Tunisia in 1986 and in Algeria 
in 1990, as well as one Tunisian serotype 3 wild strain 
isolated in 1988 were also sequenced. The nucleotide 
sequence relationships among Tunisian strains and their 
relationship with other polioviruses that have circulated 
in Mediterranean and African countries are represented 
in dendrograms (Fig. 2, polio 3; Fig. 3, polio 1 
sequences). All Tunisian polio 3 sequences grouped 
into a single cluster representing a separate genotype. 
The most closely related strain available in the 
Netherlands laboratory database was also from Tunisia 
and was isolated in 1985. The oldest strains from 1985 
and 1988 were more related to each other than the two 
later strains from 1991 to 1994. These results illustrate 
continuous circulation of a Tunisian genotype 3 
poliovirus between 1985 and 1994. With regard to 
the polio 1 viruses, the strain from Algeria and the 
Tunisian strain from 1986 were related to each other 
(6% difference in the nucleotide sequences), but no 
other related sequence was identified in the database. 
The Tunisian isolate from 1994 was completely differ- 
ent from the other two isolates and is in fact also 
distinct from known genotypes - there is >18% 
difference from the most related sequences within the 
database. It is difficult to postulate an origin for this 
isolate. 
Discussion 
In 1988, the World Health Assembly (WHA) committed 
WHO to the global eradication of poliomyelitis by the 
year 2000 [ 11. Surveillance of cases of poliomyelitis and 
of the circulation of wild-type poliovirus in man plays a 
crucial role in attaining this goal. AFP surveillance, 
although non-specific for the detection of poliovirus 
infections, has been found to be the most sensitive 
strategy. AFP encompasses a range of disorders 
including Guillain-Barrk syndrome and paralysis asso- 
ciated with non-polio enteroviruses; thus, virological 
analysis of clinical specimens must be undertaken to 
investigate the possible aetiological role of wild 
polioviruses. Nucleotide sequence analysis of the 
VP1/2A junction region of the poliovirus genome has 
proved to be an excellent tool for genotyping poliovirus 
strains from different geographic regions [ 19-22,241, 
although the analysed sequence is only 150 nucleotides 
long. A genotype is generally defined as a group of 
polioviruses having < 15% nucleotide differences within 
the VP1/2A region [19]. Sequence comparisons of 
poliovirus isolates have revealed the existence of 
numerous genotypes endemic to different regions of 
the world [19,21,22,25,31]. The high frequency of 
international travel increases the risk of inter-country 
transmission of poliovirus worldwide. Importation of 
polioviruses from endemic countries to basically polio- 
free areas has been reported [22,3 1-37]. 
Fig. 2. Sequence relatedness among polio 3 strains. Dendrogram summarising sequence relatedness among polio 3 
strains across the nucleotides 3287-3436 in the VP1/2A region [20]. The strains are designated by their serotype, 
laboratory number, country and year of isolation respectively. The name of the district of isolation is given between 
the serotype and the laboratory number for strains analysed in this study. The other strains belong to the international 
database (RIVM-Bilthoven, the Netherlands). Country abbreviations for Figs. 2 and 3 are: ALG, Algeria; COL, 
Colombia; CUP, Cyprus; EGY, Egypt; ETH, Ethiopia; FIN, Finland; IND, India; IRQ, Iraq; ISR, Israel; JOR, Jordan; 
KEN, Kenya; NET, Netherlands; SOM, Somalia; SRL, Sri Lanka; SUD, Sudan; SYR, Syria; TUN, Tunisia; TUR, 
Turkey; USA, United States of America. Percentage nucleotide sequence divergence is indicated above the dendrogram 
branches. The two Tunisian strains in the low part of the dendrogram are vaccine-related. 
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Fig. 3. Sequence relatedness among polio 1 strains. Dendrogram summarising sequence relatedness among polio 1 
strains across the nucleotides 3296-3445 in the VP1/2A region [20]. Strain designation and abbreviations are as 
defined in the legend to Fig. 2. 
In Tunisia, a national programme for virological 
surveillance of AFP cases was started at the end of 
199 1. The AFP case detection rate increased gradually 
and became >1 case/100000 infants <15 years of 
age since 1995. This rate is the minimum required and 
used by WHO as a performance indicator to monitor 
the sensitivity of case detection by National Surveil- 
lance Programmes [38]. From 1991 to 1996, this 
laboratory investigated 152 AFP cases and 1762 of 
their contacts. A total of 2088 stool samples was 
analysed with 10 1 individuals proving poliovirus 
positive. All polioviruses were investigated for their 
wild or vaccine-related origin by two methods and 
genotypes were studied by partial genome sequencing 
of 12 selected representative strains. The last cases of 
paralytic poliomyelitis in Tunisia occurred between 
December 1991 and April 1992: six cases caused by 
wild polio 3 virus were reported and, because < 1% of 
infected children show signs of AFP, the number of 
asymptomatic infections was estimated at between 600 
and 6000. This ‘outbreak’ or ‘resurgence’ of the 
disease after >2 polio-free years could be simply the 
result of the improved surveillance system or due to 
the introduction of a new genotype into the country. In 
this study, all Tunisian polio 3 strains were found to 
belong to the same genotype: strains isolated in 1992 
and 1994 were most closely related to the Tunisian 
strains isolated in 1985, which illustrates continuous 
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circulation of a Tunisian polio 3 genotype between 
1985 and 1994 and suggests that there is apparently 
no virus importation from other countries of the 
African and Mediterranean regions. The Tunisian polio 
1 strain isolated in 1986 was closely related to an 
Algerian strain isolated in 1990 (6% difference in 
nucleotide sequence). Accordingly, the two strains 
could represent a country/region specific genotype. In 
contrast, the wild polio 1 isolate in 1994 (PV1/ 
MED 125/TUN94) had > 18% dissimilarity to that 
isolated in 1986. No other related sequence could be 
found among strains that have been circulating in the 
Mediterranean and African region and, thus, its origin 
remains unclear. This strain could represent a second 
Tunisian genotype or a virus imported from another 
country where the circulating polioviruses are incom- 
pletely characterised. Genotypic analysis of circulating 
polio strains is incomplete in some areas of the world 
[31]; the Maghrebian region is an example of such an 
area and this highlights the importance of the present 
study. However, a more comprehensive view will 
require examination of isolates from neighbouring 
countries. Although long range importation of polio- 
viruses does occur [19,22,31-37, 391, most transmis- 
sion takes place between adjacent areas [31] and 
poliomyelitis control strategies are more effective if 
undertaken at a regional level. 
The other finding of this study was that, during the 
last decade, all polio type 2 viruses circulating in 
Tunisia were vaccine-related and most wild-type 
viruses belonged to the serotype 3 with a single 
genotype. These results reflect effective control stra- 
tegies within the country. As vaccine coverage in- 
creases in a region, there is a decrease in poliomyelitis 
cases followed by a decrease in the genetic variability 
of circulating polioviruses and the most rapid 
disappearance of serotype 2 [25,31,40]. The con- 
tinued circulation of wild-type 2 polioviruses is an 
indication of serious deficiencies in polio vaccine 
coverage. Wild type 2 poliovirus circulation was 
sharply reduced, presumably because of the greater 
immune protection afforded by type 2 infection than 
by the two other serotypes [41]. The fact that most 
wild viruses isolated in Tunisia in the last decade 
belong to serotype 3 and that infection occurred in 
fully vaccinated children could be due to the 
incomplete protection of Tunisian OPV vaccinated 
children against this serotype. Low seroconversion 
rates to polio 3 in fully vaccinated Tunisian infants 
have been reported already [42], which is certainly the 
principal factor contributing to persistent circulation of 
wild type 3 poliovirus, in spite of a high OPV 
coverage. Several studies have reported poliomyelitis 
outbreaks and poliovirus circulation in fully vaccinated 
populations [43 -471. This illustrates that achieving 
high routine vaccination coverage rate is insufficient to 
eradicate the disease. The re-emergence of paralytic 
poliomyelitis in 1991-1992 in Tunisia, after >2 years 
of no polio paralytic case detection, and the re- 
isolation of the same indigenous strain in 1994, in 
spite of a high OPV coverage for many years and 
intensive OPV vaccination campaigns conducted in 
1992 in response to the six polio cases, underlines the 
extreme difficulties in interrupting the circulation of 
wild polioviruses in a region. There remains a need 
for surveillance in countries with intensive OPV 
vaccination strategies and where the disease has 
apparently been eradicated. This also highlights the 
efforts that still are to be undertaken in endemic areas. 
It is likely that by now the circulation of wild 
polioviruses in Tunisia has been interrupted, as routine 
immunisation has been supplemented by annual 
National Immunization Days (NIDs) since 1995. This 
strategy has proved highly effective in interrupting 
wild virus circulation in many regions of the world 
[48-501. However, this positive impact can be stated 
only after several years of no detection of wild viruses 
in the presence of a highly effective AFP surveillance 
programme. 
We thank the Directory of Primary Health Care in Tunisia, with 
special thanks to Dr Mohsni Ezzeddine and the National staff of the 
Ministry of Health at all levels, for their efforts in the field work as 
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References 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
World Health Assembly (41st) Geneva, 2-13 May. Global 
eradication of polio by the year 2000. Resolutions and 
decisions. WHO (Resolution WHA 41,28) 1988; 26. 
World Health Organization. Performance of Acute Flaccid 
Paralysis (AFP) surveillance and incidence of poliomyelitis, 
1996-1997. Wkly Epidemiol Rec 1997; 72:  208-210. 
van Wezel AL, Hazendonk AG. Intratypic serodifferentiation of 
poliomyelitis virus strains by strain-specific antisera. Intervir- 
Crainic R, Couillin P, Blonde1 B, Cabau N, Bouk A, 
Horodniceanu F. Natural variation of poliovirus neutralization 
epitopes. Infect Immun 1983; 41: 1217-1225. 
Osterhaus ADME, van Wezel AL, Hazendonk TG, UytdeHaag 
FGCM, van Asten JAAM, van Steenis B. Monoclonal 
antibodies to polioviruses. Comparison of intratypic strain 
differentiation of poliovirus type 1 using monoclonal antibodies 
versus cross-absorbed antisera. Intervirology 1983; 20: 
Glikmann G, Moynihan M, Petersen I, Vestergaard BF. 
Intratypic differentiation of poliovirus strains by enzyme-linked 
immunosorbent assay (ELISA): poliovirus type 1. Dev Biol 
Stand 1983; 55: 199-208. 
Ferguson M, Macgrath DI, Minor PD, Schild GC. WHO 
collaborative study on the use of monoclonal antibodies for the 
intratypic differentiation of poliovirus strains. Bull World 
Health Organ 1986; 64: 239-246. 
Hyypia T, Auvinen P, Maaronen M. Polymerase chain reaction 
for human picornaviruses. J Gen Virol 1989; 70: 3261-3268. 
Chapman NM, Tracy S, Gauntt CJ, Fortmueller U. Molecular 
detection and identification of enteroviruses using enzymatic 
amplification and nucleic acid hybridization. J Clin Microbiol 
Olive DM, Al-Mufti S, Al-Mulla W et al. Detection and 
differentiation of picornaviruses in clinical samples following 
genomic amplification. J Gen Virol 1990; 71: 2141-2147. 
Petitjean J, Quibraic M, Freymuth F et al. Specific detection of 
enteroviruses in clinical samples by molecular hybridization 
using poliovirus subgenomic riboprobes. J Clin Microbiol 
Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R. 
The natural genomic variability of poliovirus analyzed by a 
0 1 0 ~  1979; 11: 2-8. 
129- 136. 
1990; 28: 843-850. 
1990; 28: 307-31 1. 
Downloaded from www.microbiologyresearch.org by
IP:  157.99.52.17
On: Tue, 25 Jun 2019 09:31:22
576 H. TRIKI ETAL.  
restriction fragment length polymorphism assay. Virology 199 1 ; 
13. da Silva EE, Pallansch MA, Holloway BP, Oliveira MJC, 
Schatzmayr HG, Kew OM. Oligonucleotide probes for the 
specific detection of the wild poliovirus types 1 and 3 endemic 
to Brazil. Intewirology 1991; 32: 149-159. 
14. Yang CF, De L, Holloway BP, Pallansch MA, Kew OM. 
Detection and identification of vaccine-related polioviruses by 
the polymerase chain reaction. Virus Res 1991; 20: 159-179. 
15. Kammerer U, Kunkel B, Korn K. Nested PCR for specific 
detection and rapid identification of human picornaviruses. 
J Clin Microbiol 1994; 32: 285-291. 
16. Schweiger B, Schreier E, Bothig B, Lopez-Pila JM. Differ- 
entiation of vaccine and wild-type polioviruses using poly- 
merase chain reaction and restriction enzyme analysis. Arch 
Mrol 1994; 134: 39-50. 
17. Takeda N, Sakae K, Agboatwalla M, Isomura S, Hondo R, 
Inouye S. Differentiation between wild and vaccine-derived 
strains of poliovirus by stringent microplate hybridization of 
PCR products. J Clin Microbiol 1994; 32: 202-204. 
18. De L, Nottay B, Yang C-F, Holloway BP, Pallansch MA, Kew 0. 
Identification of vaccine-related polioviruses by hybridization 
with specific RNA probes. J Clin Microbiol 1995; 33: 562-571. 
19. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM. 
Geographic distribution of wild poliovirus type 1 genotypes. 
Virology 1987; 160: 311-322. 
20. Kew OM, Nottay BK, Rico-Hesse R, Pallansch MA. Molecular 
epidemiology of wild poliovirus transmission. In: Kurstak E, 
Marusyk RG, Murphy FA, Van Regenmortel MHV (eds) 
Applied virology research, Vol 2. Virus variability, epidemiol- 
ogy, and control. New York, Plenum Medical Book Co. 1990: 
21. Kew OM, Pallansch MA, Nottay BK Rico-Hesse RR, De L. 
Yang C-F. Genotype relationships among wild polioviruses 
from different regions of the world. In: Brinton MA, Heinz FX 
(eds) New aspects of positive-strand RNA viruses. Washington, 
DC, American Society for Microbiology. 1990: 357-365. 
22. Poyry T, Kinnunen L, Kapsenberg J, Kew 0, Hovi T. Type 3 
poliovirus/Finland/ 1984 is genetically related to common 
Mediterranean strains. J Gen Virol 1990; 71: 2535-2541. 
23. Kew 0, De L, Yang CF, Nottay B, da Silva E, Pallansch M. 
The role of virlologic surveillance in the global initiative to 
eradicate poliomyelitis. In: Kustak E (ed) Control of virus 
diseases, 2nd edn. New York, Marcel Dekker. 1993: 215-246. 
24. Zheng D-P, Zhang L-B, Fang Z-Y et al. Distribution of wild 
type 1 poliovirus genotypes in China. J Infect Dis 1993; 168: 
25. Mulders MN, Lipskaya GY, van der Avoort HGAM, Koopmans 
MPG, Kew OM, van Loon AM. Molecular epidemiology of 
wild poliovirus type 1 in Europe, the Middle East, and the 
Indian subcontinent. J Infect Dis 1995; 171: 1399-1405. 
26. Triki H, Arrouji A, Dellagi K. [Acute anterior poliomyletitis. 
Situation in Tunisia during 1991 -1992.1 La poliomyilite 
Antkrieure AigGe: situation en Tunisie en 199 1 - 1992. Arch 
Inst Pasteur Tunis 1992; 69: 21-27. 
27. Expanded Programme on Immunization. Surveillance for polio 
- the Tunisia experience. EPI Alert 1993; 8: 7. 
28. World Health Organization. Poliomyelitis eradication - Tunisia. 
Wkly Epidemiol Rec 1994; 46: 344-347. 
29. World Health Organization. Manual for the virological 
investigation of poliomyelitis. Geneva, WHO. 1992 (WHO/ 
EPI/CDS/POLI0/90.1). 
30. van der Avoort HGAM, Hull BP, Hovi T et al. Comparative 
study of five methods for intratypic differentiation of polio- 
viruses. J Clin Microbiol 1995; 33: 2562-2566. 
184: 645-654. 
199-22 1. 
1361-1367. 
31. Kew OM, Mulders MN, Lipskaya GY et al. Molecular 
epidemiology of polioviruses. Seminars Virology 1995; 6: 
32. Mulders MN, van Loon AM, van der Avoort HGAM et al. 
Molecular characterization of wild poliovirus type 3 epidemic 
in the Netherlands (1992 and 1993). J Clin Microbiol 1995; 
33. Bernal A, Garcia-Saiz A, Liacer A, de Ory F, Tell0 0, Najera 
R. Poliomyelitis in Spain, 1982-1984: virologic and epide- 
miologic studies. Am J Epidemiol 1987; 126: 69-76. 
34. Varughese PV, Carter AO, Acres SE, Furesz J. Eradication of 
indigenous poliomyelitis in Canada: impact of immunization 
strategies. Can J Public Health 1989; 80: 363-368. 
35. World Health Organization. Expanded programme on immuni- 
zation. Poliomyelitis outbreak: Bulgaria. wkry Epidemiol Rec 
36. World Health Organization. Expanded programme on immuni- 
zation. Poliomyelitis outbreak: Malaysia. Wkly Epidemiol Rec 
37, Oostvogel PM, van Wijngaarden JK, van der Avoort HGAM et 
al. Poliomyelitis outbreak in an unvaccinated community in the 
Netherlands, 1992-93. Lancet 1994; 344: 665-670. 
38. Hull HF, Birmingham ME, Melgaard B, Lee JW. Progress 
toward global polio eradication. J Infect Dis 1997; 175 Suppl 
1: s4-s9. 
39. Pan American Health Organization. Polio incidence rises in 
Brazil northeast. EPI News1 1986; 8: 4-5. 
40. World Health Organization Collaborative Study Group on Oral 
Poliovirus Vaccine. Factors affecting the immunogenicity of 
oral poliovirus vaccine: a prospective evaluation in Brazil and 
the Gambia. J Infect Dis 1995; 171 1097-1106. 
4 1. Hull BP, Dowdle WR. Poliovirus surveillance: building the 
global polio laboratory network. J Infect Dis 1997; 175 Suppl 
42. Triki H, Ould Mohamed Abdallah MY Ben Aissa R et al. 
Influence of host related factors on the antibody response to 
trivalent oral polio vaccine in Tunisian infants. Vaccine 1997; 
43. Kim-Farley RJ, Rutherford G, Lichfield P et al. Outbreak of 
paralytic poliomyelitis, Taiwan. Lancet 1984; 2: 1322- 1324. 
44. Sutter RW, Patriarca PA, Brogan S et al. Outbreak of para- 
lytic poliomyelitis in Oman: evidence for widespread transmis- 
sion among fully vaccinated children. Lancet 199 1 ; 338: 
45. Chiba Y, Xu A, Li L et al. Outbreaks of paralytic poliomyelitis 
and polio surveillance in Shandong province of China. Jpn J 
Med Sci Biol 1992; 45: 255-266. 
46. Deming MS, Jaiteh KO, Otten MW et al. Epidemic polio- 
myelitis in the Gambia following the control of poliomyelitis 
as an endemic disease. 11. Clinical efficacy of trivalent oral 
polio vaccine. Am J Epidemiol 1992; 135: 393-408. 
47. Otten MW, Deming MS, Jaiteh KO et al. Epidemic 
poliomyelitis in the Gambia following the control of polio- 
myelitis as an endemic disease. 1. Descriptive findings. Am J 
Epidemiol 1992; 135: 381-392. 
48. Birmingham ME, Aylward RB, Cochi SL, Hull HF. National 
immunization days: state of the art. J Infect Dis 1997; 175 
49. Olivb J-M, Risi JB, de Quadros CA. National immunization 
days: experience in Latin America. J Infect Dis 1997; 175 
50. Bilous J, Maher C, Tangermann RH et al. The experience of 
countries in the Western Pacific Region in conducting National 
immunization days for poliomyelitis eradication. J Infect Dis 
40 1-4 14. 
33: 3252-3256. 
1992; 67: 336-337. 
1993; 68: 297-300. 
1: S113-S116. 
15: 1123-1 129. 
7 15-720. 
SUppl 1: S183-S188. 
Suppl 1: S189-S193. 
1997; 175 Suppl 1: S194-S197. 
